Toll Free: 1-888-928-9744

Vitamin D Deficiency Disorders Global Clinical Trials Review, H1, 2016

Published: Apr 20, 2016 | Pages: 355 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Vitamin D Deficiency Disorders Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, "Vitamin D Deficiency Disorders Global Clinical Trials Review, H1, 2016" provides an overview of Vitamin D Deficiency Disorders clinical trials scenario. This report provides top line data relating to the clinical trials on Vitamin D Deficiency Disorders. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Vitamin D Deficiency Disorders to Nutritional Disorders Clinical Trials 15 Clinical Trials by Phase in G7 Countries 17 Clinical Trials in G7 Countries by Trial Status 18 Clinical Trials by E7 Countries: Proportion of Vitamin D Deficiency Disorders to Nutritional Disorders Clinical Trials 19 Clinical Trials by Phase in E7 Countries 20 Clinical Trials in E7 Countries by Trial Status 21 Clinical Trials by Phase 22 In Progress Trials by Phase 23 Clinical Trials by Trial Status 24 Clinical Trials by End Point Status 25 Subjects Recruited Over a Period of Time 26 Clinical Trials by Sponsor Type 27 Prominent Sponsors 28 Top Companies Participating in Vitamin D Deficiency Disorders Therapeutics Clinical Trials 29 Prominent Drugs 31 Latest Clinical Trials News on Vitamin D Deficiency Disorders 32 Apr 01, 2016: OPKO Presents Additional Data on RAYALDEE at ENDO 2016 32 Clinical Trial Profile Snapshots 33 Appendix 352 Abbreviations 352 Definitions 352 Research Methodology 353 Secondary Research 353 About GlobalData 354 Contact Us 354 Disclaimer 354 Source 355
List of Tables
Vitamin D Deficiency Disorders Therapeutics, Global, Clinical Trials by Region, 2016* 6 Vitamin D Deficiency Disorders Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8 Vitamin D Deficiency Disorders Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10 Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11 Vitamin D Deficiency Disorders Therapeutics Clinical Trials, North America, Top Countries, 2016* 12 Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13 Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 14 Proportion of Vitamin D Deficiency Disorders to Nutritional Disorders Clinical Trials, G7 Countries (%), 2016* 16 Vitamin D Deficiency Disorders Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 17 Vitamin D Deficiency Disorders Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 18 Proportion of Vitamin D Deficiency Disorders to Nutritional Disorders Clinical Trials, E7 Countries (%), 2016* 19 Vitamin D Deficiency Disorders Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 20 Vitamin D Deficiency Disorders Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 21 Vitamin D Deficiency Disorders Therapeutics, Global, Clinical Trials by Phase, 2016* 22 Vitamin D Deficiency Disorders Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 23 Vitamin D Deficiency Disorders Therapeutics, Global, Clinical Trials by Trial Status, 2016* 24 Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Global, by End Point Status, 2016* 25 Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 26 Vitamin D Deficiency Disorders Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 27 Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 28 Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 30 Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 31


List of Figures
Vitamin D Deficiency Disorders Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Vitamin D Deficiency Disorders Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Vitamin D Deficiency Disorders Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10 Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11 Vitamin D Deficiency Disorders Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12 Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13 Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 14 Proportion of Vitamin D Deficiency Disorders to Nutritional Disorders Clinical Trials, G7 Countries (%), 2016* 15 Vitamin D Deficiency Disorders Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 17 Vitamin D Deficiency Disorders Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 18 Proportion of Vitamin D Deficiency Disorders to Nutritional Disorders Clinical Trials, E7 Countries (%), 2016* 19 Vitamin D Deficiency Disorders Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 20 Vitamin D Deficiency Disorders Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 21 Vitamin D Deficiency Disorders Therapeutics, Global, Clinical Trials by Phase (%), 2016* 22 Vitamin D Deficiency Disorders Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 23 Vitamin D Deficiency Disorders Therapeutics, Global, Clinical Trials by Trial Status, 2016* 24 Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Global, by End Point Status, 2016* 25 Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 26 Vitamin D Deficiency Disorders Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 27 Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 28 Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29 Vitamin D Deficiency Disorders Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 31 GlobalData Methodology 353

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global Biocides market size is likely to be valued at USD 11.9 billion by 2022; as per a new research report by Radiant Insights, Inc. Growth in water treatment process units particularly in China, Japan and India is likely to drive demand. Increasin

Read More...

Global 3D scanning market is expected to be valued at USD 4,900.7 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing need for speedy and precise results with high efficiency is anticipated to drive the industry. 3D

Read More...

Global coated fabrics market size forecast is estimated at USD 22.57 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing production of seat covers & airbags for automobile applications is likely to favor market growth.

Read More...

North America air conditioner market size is expected to be valued at USD 52,560.7 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing usage of energy efficient air conditioners owing to declining energy consumption rat

Read More...

Global agricultural films market size is anticipated to reach USD 10.5 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to raise agricultural productivity, in order to meet surplus demand by growing population i

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify